Ulrike Bockmuehl

Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis

Ronald Koschny, Heidrun Holland, Jaromir Sykora et al. · Journal of Neuro-Oncology · 2009 · 20 citations

Life Sciences, Oncology, Pharmacology +14

Is PET superior to MRI in the pretherapeutic evaluation of head and neck squamous cell carcinoma?

Amir Minovi, A. Hertel, Ahmet Ural et al. · PubMed · 2007 · 13 citations

Medicine, Oncology, Diagnostic Imaging +14

Induction chemotherapy (IC) docetaxel (T), cisplatin (P), 5-fluorouracil (F) (TPF), or TP followed by concomitant boost radiotherapy (R) with or without cetuximab (E) for functional organ preservation (FOP) of resectable laryngeal and hypopharyngeal cancer (LHSCC): First results of the phase II randomized DeLOS-II study.

Andreas Dietz, Michael Flentje, Rudolf Hagen et al. · Journal of Clinical Oncology · 2014 · 12 citations

Medicine, Oncology, Surgery +15